233 related articles for article (PubMed ID: 21041923)
1. Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.
Ruiz-Carrascoso G; Casas I; Pozo F; González-Vincent M; Pérez-Breña P
Antivir Ther; 2010; 15(7):1059-63. PubMed ID: 21041923
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
[TBL] [Abstract][Full Text] [Related]
3. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
4. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
Abed Y; Baz M; Boivin G
J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
[TBL] [Abstract][Full Text] [Related]
5. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.
Piralla A; Gozalo-Margüello M; Fiorina L; Rovida F; Muzzi A; Colombo AA; Alessandrino PE; Baldanti F
J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646
[TBL] [Abstract][Full Text] [Related]
6. Emergence and phylogenetic analysis of amantadine-resistant influenza a subtype H3N2 viruses in Dublin, Ireland, over Six Seasons from 2003/2004 to 2008/2009.
Salter A; Ni Laoi B; Crowley B
Intervirology; 2011; 54(6):305-15. PubMed ID: 21228542
[TBL] [Abstract][Full Text] [Related]
7. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of influenza A(H3N2) virus from 2007 to 2012].
Vopr Virusol; 2013; 58(6):27-31. PubMed ID: 24772643
[TBL] [Abstract][Full Text] [Related]
9. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
[TBL] [Abstract][Full Text] [Related]
10. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
11. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007.
Dapat C; Saito R; Kyaw Y; Naito M; Hasegawa G; Suzuki Y; Dapat IC; Zaraket H; Cho TM; Li D; Oguma T; Baranovich T; Suzuki H
Intervirology; 2009; 52(6):310-20. PubMed ID: 19776616
[TBL] [Abstract][Full Text] [Related]
13. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.
Hata M; Tsuzuki M; Goto Y; Kumagai N; Harada M; Hashimoto M; Tanaka S; Sakae K; Kimura T; Minagawa H; Miyazaki Y
Jpn J Infect Dis; 2007 Jul; 60(4):202-4. PubMed ID: 17642534
[TBL] [Abstract][Full Text] [Related]
14. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.
Baz M; Abed Y; McDonald J; Boivin G
Clin Infect Dis; 2006 Dec; 43(12):1555-61. PubMed ID: 17109288
[TBL] [Abstract][Full Text] [Related]
15. Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.
Okomo-Adhiambo M; Demmler-Harrison GJ; Deyde VM; Sheu TG; Xu X; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2010 May; 54(5):1834-41. PubMed ID: 20194700
[TBL] [Abstract][Full Text] [Related]
16. Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient.
Hurt AC; Leang SK; Tiedemann K; Butler J; Mechinaud F; Kelso A; Downie P; Barr IG
Influenza Other Respir Viruses; 2013 Nov; 7(6):904-8. PubMed ID: 23551973
[TBL] [Abstract][Full Text] [Related]
17. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
[TBL] [Abstract][Full Text] [Related]
18. Global transmission of oseltamivir-resistant influenza.
Moscona A
N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
[No Abstract] [Full Text] [Related]
19. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
[TBL] [Abstract][Full Text] [Related]
20. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.
Nguyen HT; Fry AM; Loveless PA; Klimov AI; Gubareva LV
Clin Infect Dis; 2010 Oct; 51(8):983-4. PubMed ID: 20858074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
